Ocular Melanoma Trial; Hepatitis C Link to Cataract

The first cases using candidate (AU-011; Aura Biosciences) for treating ocular melanoma are performed at Wills Eye Hospital in Philadelphia; the National Eye Institute outlines its Audacious Goals Initiative, which provides recommendations for regenerating retinal ganglion cells. Also, a large population-based study suggests hepatitis C infection may increase the risk of cataracts.